Drug Status Not Stopping Education Effort
Houston Chronicle - United States
BOSTON — It was barely two hours after a panel recommended to the Food and Drug Administration that it allow the drug Tysabri back on the market when Dr ...

---

Like Lieberman, Thorp had two treatments with Tysabri before it was pulled. Unlike Lieberman, she is desperate for the drug's return to the market. After the two treatments she said she noticed improvement in her motor skills.

"I was just devastated when they took it off the market," she said. "To me, it was well worth a shot."